EichorEICHOR
Location: Bayreuth Synced from ClinicalTrials.gov · August 10, 2026

Clinical studies recruiting near Bayreuth

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Klinikum Bayreuth · Goethe University · NCT02872987NG004 in Spinal Cord Injury Patients
Phase 1 · Klinik für Querschnittgelähmte, Klinikum Bayreuth · NovaGo Therapeutics AG · NCT06817577A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06830720Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Local Institution - 2403 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Phase 1/Phase 2 · Klinikum Bayreuth GmbH · Stemline Therapeutics, Inc. · NCT05386108A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · Local Institution - 2403 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05511363Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring in Patients with Lung Cancer
NA · Hospital Bayreuth · University of Bayreuth · NCT06252233A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05344469PROCARE - PROstate Cancer Real World Evidence Registry
Phase N/A · Hospital Bayreuth GmbH · UroTrials Company (GmbH) · NCT06835218Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+
Phase 2 · Klinikum Bayreuth · GBG Forschungs GmbH · NCT06201234Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Register Study Including Pe
Phase N/A · Klinikum Bayreuth · University of Erlangen-Nürnberg Medical School · NCT07721701A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Phase 3 · Research Site · AstraZeneca · NCT05774951Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT
Phase 2 · Klinikum Bayreuth · Goethe University · NCT06061094A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myel
Phase 3 · Universitatsklinikum Bayreuth, Med. Klinik IV · Takeda · NCT07422480Functional Impact of Acute Respiratory Viral Infections in Older Adults
Phase N/A · Klinikum Bayreuth, Klinik für Geriatrie · University Hospital, Grenoble · NCT07388173A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Phase 3 · Klinikum Bayreuth Standort Hohe Warte Klinik fur Neurologie · Hoffmann-La Roche · NCT07169578Praegnant Breast Cancer: Early/Advanced/Metastatic
Phase N/A · Klinikum Bayreuth · University Hospital Tuebingen · NCT02338167Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)
Phase N/A · Klinikum Bayreuth GmbH · Technische Universität Dresden · NCT03188874Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subje
Phase 3 · Klinikum Bayreuth GmbH · Greenwich LifeSciences, Inc. · NCT05232916Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognit
NA · Klinikum Bayreuth GmbH - Klinik Hohe Warte · Société des Produits Nestlé (SPN) · NCT06347315A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 2 · Klinikum Bayreuth GmbH · Takeda · NCT04419649Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)
Phase 3 · Klinikum Bayreuth · Dominik Paul Modest · NCT05008809E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
Phase N/A · Klinikum Bayreuth Gmbh · European Organisation for Research and Treatment of Cancer - · NCT03818503
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.